173 related articles for article (PubMed ID: 18379981)
1. Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials.
Kethireddy S; Safdar N
J Vasc Access; 2008; 9(1):51-7. PubMed ID: 18379981
[TBL] [Abstract][Full Text] [Related]
2. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.
Safdar N; Maki DG
Clin Infect Dis; 2006 Aug; 43(4):474-84. PubMed ID: 16838237
[TBL] [Abstract][Full Text] [Related]
3. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
Maki DG; Kluger DM; Crnich CJ
Mayo Clin Proc; 2006 Sep; 81(9):1159-71. PubMed ID: 16970212
[TBL] [Abstract][Full Text] [Related]
4. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
5. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
Arora RS; Roberts R; Eden TO; Pizer B
Cochrane Database Syst Rev; 2010 Dec; (12):CD007785. PubMed ID: 21154387
[TBL] [Abstract][Full Text] [Related]
6. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.
Crnich CJ; Maki DG
Clin Infect Dis; 2002 May; 34(10):1362-8. PubMed ID: 11981732
[TBL] [Abstract][Full Text] [Related]
7. Weekly prophylactic urokinase instillation in tunneled central venous access devices.
Ray CE; Shenoy SS; McCarthy PL; Broderick KA; Kaufman JA
J Vasc Interv Radiol; 1999; 10(10):1330-4. PubMed ID: 10584647
[TBL] [Abstract][Full Text] [Related]
8. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
Pittiruti M; Bertoglio S; Scoppettuolo G; Biffi R; Lamperti M; Dal Molin A; Panocchia N; Petrosillo N; Venditti M; Rigo C; DeLutio E
J Vasc Access; 2016 Nov; 17(6):453-464. PubMed ID: 27516141
[TBL] [Abstract][Full Text] [Related]
10. Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients.
Horne MK; Mayo DJ
J Clin Oncol; 1997 Jul; 15(7):2709-14. PubMed ID: 9215844
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
[TBL] [Abstract][Full Text] [Related]
12. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
13. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.
Yahav D; Rozen-Zvi B; Gafter-Gvili A; Leibovici L; Gafter U; Paul M
Clin Infect Dis; 2008 Jul; 47(1):83-93. PubMed ID: 18498236
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
Zanon C; Bortolini M; Chiappino I
Tumori; 2005; 91(6):477-80. PubMed ID: 16457145
[TBL] [Abstract][Full Text] [Related]
17. Interventions for restoring patency of occluded central venous catheter lumens (Review).
van Miert C; Hill R; Jones L
Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
[No Abstract] [Full Text] [Related]
18. Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.
Pérez-Granda MJ; Barrio JM; Muñoz P; Hortal J; Rincón C; Rabadán PM; Pernia MS; Bouza E
PLoS One; 2014; 9(3):e91838. PubMed ID: 24675993
[TBL] [Abstract][Full Text] [Related]
19. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution.
Souza Dias MB; Habert AB; Borrasca V; Stempliuk V; Ciolli A; Araújo MR; Costa SF; Levin AS
Infect Control Hosp Epidemiol; 2008 Feb; 29(2):125-30. PubMed ID: 18179367
[TBL] [Abstract][Full Text] [Related]
20. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters.
Garland JS; Alex CP; Sevallius JM; Murphy DM; Good MJ; Volberding AM; Hofer LL; Gordon BJ; Maki DG
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):243-9. PubMed ID: 18220483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
